Cargando…
Anti-Leishmanial Vaccines: Assumptions, Approaches, and Annulments
Leishmaniasis is a neglected protozoan parasitic disease that occurs in 88 countries but a vaccine is unavailable. Vaccination with live, killed, attenuated (physically or genetically) Leishmania have met with limited success, while peptide-, protein-, or DNA-based vaccines showed promise only in an...
Autores principales: | Zutshi, Shubhranshu, Kumar, Sunil, Chauhan, Prashant, Bansode, Yashwant, Nair, Arathi, Roy, Somenath, Sarkar, Arup, Saha, Bhaskar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963565/ https://www.ncbi.nlm.nih.gov/pubmed/31635276 http://dx.doi.org/10.3390/vaccines7040156 |
Ejemplares similares
-
TLR–CD40 Cross-Talk in Anti-Leishmanial Immune Response
por: Chandel, Himanshu Singh, et al.
Publicado: (2014) -
Conceptual Evolution of Cell Signaling
por: Nair, Arathi, et al.
Publicado: (2019) -
March of Mycobacterium: miRNAs intercept host cell CD40 signalling
por: Chauhan, Prashant, et al.
Publicado: (2020) -
Residue-Specific Message Encoding in CD40-Ligand
por: Sarode, Aditya Yashwant, et al.
Publicado: (2020) -
Leishmanial Abscess
por: Arora, Sandeep, et al.
Publicado: (2017)